One incredibly expensive drug for GSK.

FDA: Diabetes Drug Avandia To Be Pulled From Retail Pharmacies In November

For several years, prescription diabetes medicine Avandia has been at the center of a debate about whether the medication’s heart attack risk was high enough to pull it from pharmacies. Now, nearly eight months after the FDA announced it would be introducing strict restrictions on its sale and use, the agency has finally gotten around to announcing the specifics of those restrictions. [More]